STLN STARLING ONCOLO

NASDAQ
$3.50

STARLING ONCOLO (STLN) Earnings News

Earnings press releases, previews and reviews for STARLING ONCOLO (STLN), newest first. Our most recent is review: Starling Oncology Misses on GAAP EPS, Beats on EBITDA, but a Capitation Guidance Cut Undercuts the Growth Story.